We are live on !
Find out more
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
Turnover
60.27%
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.6B
AUM Growth
+$1.42B
(+10%)
Cap. Flow
+$81.1M
Cap. Flow % of AUM
Cap. Flow %
0.52%
Top 10 Holdings %
Top 10 Hldgs %
22.3%
Holding
1,397
New
435
Increased
253
Reduced
266
Closed
407
Avg Time Held
Equity + Options
0.3
years
Top 10 Avg Time Held
Equity + Options
0.2
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$311M |
| 2 |
Abbott
ABT
|
+$125M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$121M |
| 4 |
SpaceX
SPCX
|
+$116M |
| 5 |
Procter & Gamble
PG
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Datadog
DDOG
|
+$128M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$111M |
| 3 |
Elastic
ESTC
|
+$110M |
| 4 |
Twilio
TWLO
|
+$110M |
| 5 |
Intuitive Surgical
ISRG
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.5% |
| 2 | Financials | 16.81% |
| 3 | Miscellaneous | 15.64% |
| 4 | Technology | 13.57% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Voya Financial
VOYA
$8.91B
| $17M | 0.11% |
187,389
-185,288
| -50% | -$15.1M |
2025 Q2
4 quarters
|
|
227
Churchill Downs
CHDN
$5.88B
| $16.8M | 0.11% |
187,259
+170,583
| +1,023% | +$15.3M |
2026 Q1
1 quarter
|
|
228
Enphase Energy
ENPH
$4.14B
| $16.5M | 0.11% |
+334,620
| New | +$15.2M |
2026 Q2
0 quarters
|
|
229
BJs Wholesale Club
BJ
$13.5B
| $16.3M | 0.1% |
187,255
-48,771
| -21% | -$4.46M |
2026 Q1
1 quarter
|
|
230
RB Global
RBA
$15.6B
| $16.3M | 0.1% |
+139,583
| New | +$14.7M |
2026 Q2
0 quarters
|
|
231
Eli Lilly
LLY
$1.17T
| $16.1M | 0.1% |
+13,442
| New | +$13.7M |
2026 Q2
0 quarters
|
|
232
Antero Midstream
AM
$9.8B
| $15.9M | 0.1% |
698,696
+170,930
| +32% | +$3.71M |
2025 Q3
3 quarters
|
|
233
Kodiak Gas Services
KGS
$4.45B
| $15.7M | 0.1% |
209,519
+17,048
| +9% | +$1.16M |
2025 Q3
3 quarters
|
|
234
Ovintiv
OVV
$19.2B
| $15.7M | 0.1% |
298,653
-1,014,356
| -77% | -$57.9M |
2024 Q4
6 quarters
|
|
235
Aptiv
APTV
$9.09B
| $15.6M | 0.1% |
+254,954
| New | +$15.6M |
2026 Q2
0 quarters
|
|
236
Mattel
MAT
$4.84B
| $15.6M | 0.1% |
+1,120,413
| New | +$16.4M |
2026 Q2
0 quarters
|
|
237
Ecolab
ECL
$81.9B
| $15.5M | 0.1% |
55,569
+50,004
| +899% | +$13.2M |
2026 Q1
1 quarter
|
|
238
Edwards Lifesciences
EW
$51.9B
| $15.5M | 0.1% |
+171,081
| New | +$14.3M |
2026 Q2
0 quarters
|
|
239
Ralliant Corp
RAL
$7.27B
| $15.2M | 0.1% |
206,590
-255,771
| -55% | -$14.3M |
2025 Q2
4 quarters
|
|
240
ITT
ITT
$16.8B
| $15.1M | 0.1% |
76,153
+52,469
| +222% | +$10.6M |
2026 Q1
1 quarter
|
|
241
FirstEnergy
FE
$26.9B
| $15.1M | 0.1% |
+316,577
| New | +$15M |
2026 Q2
0 quarters
|
|
242
UWM Holdings
UWMC
$393M
| $14.9M | 0.1% |
6,488,779
-3,270,347
| -34% | -$10.2M |
2026 Q1
1 quarter
|
|
243
STMicroelectronics
STM
$39.5B
| $14.8M | 0.09% |
+197,342
| New | +$11.9M |
2026 Q2
0 quarters
|
|
244
Popular Inc
BPOP
$10.1B
| $14.8M | 0.09% |
+89,941
| New | +$13.6M |
2026 Q2
0 quarters
|
|
245
Patterson-UTI
PTEN
$4.32B
| $14.8M | 0.09% |
1,607,903
+1,222,978
| +318% | +$13.6M |
2026 Q1
1 quarter
|
|
246
Supernus Pharmaceuticals
SUPN
$2.45B
| $14.7M | 0.09% |
316,398
-324,921
| -51% | -$15.6M |
2025 Q4
2 quarters
|
|
247
Cameco
CCJ
$34.4B
| $14.6M | 0.09% |
143,269
-114,713
| -44% | -$12.9M |
2025 Q4
2 quarters
|
|
248
American Financial Group
AFG
$12.7B
| $14.4M | 0.09% |
103,013
+95,629
| +1,295% | +$12.7M |
2026 Q1
1 quarter
|
|
249
Aramark
ARMK
$13.8B
| $14.3M | 0.09% |
250,607
+250,274
| +75,157% | +$12.4M |
2026 Q1
1 quarter
|
|
250
State Street
STT
$46.1B
| $14.2M | 0.09% |
83,758
-187,710
| -69% | -$28.9M |
2025 Q1
5 quarters
|
|
Similar funds
Freestone Grove Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Freestone Grove Partners held 1,397 positions worth $15.6B, up 10% from $14.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Freestone Grove Partners's Q2 2026 filing shows 435 new, 253 increased, 266 reduced and 407 closed positions. Its largest new stake was Abbott: 1,372,846 shares worth $125M. The largest sale was Datadog, an estimated $128M.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 12% a quarter earlier, followed by Financials and Miscellaneous.
- Freestone Grove Partners's largest Q2 2026 buy was Abbott: 1,372,846 shares worth $125M.
- Freestone Grove Partners added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $311M increase.
- Freestone Grove Partners's biggest Q2 2026 reduction was Elastic, cutting an estimated $110M.
- Freestone Grove Partners fully exited Datadog in Q2 2026, selling an estimated $128M.
- Freestone Grove Partners's ten largest holdings make up 22% of its $15.6B portfolio in Q2 2026.
- Freestone Grove Partners opened 435 new positions and closed 407 in Q2 2026.
- Freestone Grove Partners's portfolio value rose 10% quarter-over-quarter to $15.6B.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.